CLINICAL_TRIALS
trial_result
· 2025-01-15
Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease [Phase 2]
Summary
A Phase 2 study evaluating the safety and efficacy of Rreproxalap in adults with dry eye disease has completed, with results posted in January 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2025-01-15